期刊文献+

妊娠妇女凝血功能变化的临床研究 被引量:12

Analysis of variation of women's blood coagulation function in normal pregnancy
下载PDF
导出
摘要 目的了解妊娠妇女凝血功能变化,探讨妊娠妇女凝血指标变化的规律及临床意义。方法对156例正常孕妇和20例健康非孕妇女的凝血酶原时间(PT)、部分凝血活酶时间(APTT)、凝血酶时间(TT)及纤维蛋白原(Fg)、D-二聚体(D-D)、抗凝血酶Ⅲ(AT-Ⅲ)进行检测。结果妊娠组与对照组比较,PT、APTT指标差异无统计学意义(P>0.05),且PT、APTT在妊娠早、中、晚期组间差异也无统计学意义(P>0.05);TT值在对照组、早孕组、中孕组之间差异无统计学意义(P>0.05),而晚孕组的TT检测结果较前三组明显缩短(P<0.05);妊娠组与对照组比较,AT-Ⅲ活性显著下降,差异有统计学意义(P<0.01),且随孕期增加有不断下降的趋势(P<0.01);而妊娠组的D-D、Fg水平都显著高于对照组(P<0.01),Fg在孕早、中期无明显变化(P>0.05),孕晚期明显升高(P<0.01),D-二聚体在孕早、中、晚期不断升高(P<0.01)。结论正常孕妇处于高凝状态,孕期进行凝血指标的监测,可早期发现凝血功能的异常变化,对预防和抢救产科一些并发症有重要意义。 Objective To investigate the variation of coagulation function in pregnancy. Methods Prothrombin time(PT) ,activated partial thromboplastin time(APTT), thrombin time ( TT), fibrinogen (Fbg), D-Dimer (D-D) and antithrombin Ⅲ ( AT- Ⅲ ) in fifty-two pregnant women and twenty normal non-pregnency women were determined by ACL-9000 system. Results Compared with those of the control group, the levels of PT, APTT were not obviously changed in pregnancy(P〉0.05) ;the levels of TT were obviously shorter compared with the late-pregnant women and the other group(P〈0.01) ; but there was no significant difference among the control group, the early and middle pregnant women groups(P〉 0.05) ;compared with the control group, the activity of AT- Ⅲ were obviously dropped in pregnancy(P〈0.01 ), and decreased with the progress of pregnancy( P〈 0.01 ) ; in contrast, the levels of D-D and Fg increased with the progress pregnancy(P〈0.01). Conclusion The pregnant women have the hypercoagulation state. The detection of blood concretion functions plays an important role in preventing from complications.
出处 《重庆医学》 CAS CSCD 2007年第13期1292-1293,1295,共3页 Chongqing medicine
基金 国家十五攻关课题资助项目(2004BA720A06-01)
关键词 妊娠 凝血功能 并发症 pregnancy coagulation function complications
  • 相关文献

参考文献11

  • 1Granger JP,Alexander BJ,Bennertt WA,et al.Pathophysiology of pregnancy induced hypertension[J].Am J Hypertens,2001,14(2):178.
  • 2Cerneca K,Ricci G,Simeone R,et al.Coagulation and fibrinolysis changes in normal pregnancy.Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state,combined with a reactive fibrinolysis[J].Eur J Obstet Gynecol Reprod Biol,1997,73:31.
  • 3Uchikova EH,Ledjev II.Changes in haemostasis during normal pregnancy[J].Eur J Obstet Gynecol Reprod Biol,2005,119:185.
  • 4Takamatsu J.Congenital prothrombinemia/dysprothrombinemia[J].Ryoikibetsu Shokogun Shirizu,1998,21(2):456.
  • 5Neerman M,Honsberger A,Antonarakis SE,et al.Deletion of the fibrogen alpha-chain gene causes congenital afibrinogenemia[J].J Clin Invest,1999,103(2):215.
  • 6Kemkes-Matthes B.Changes in the blood coagulation system in pregnancy[J].Z Kardiol,2001,90(4):45.
  • 7Hellgren M.Haemostasis during normal pregnancy and puerperium[J].Semin Thromb Hemost,2003,29(2):125.
  • 8Manten GTR,Sikkema JM,Franx A,et al.Increased high molecular weight fibrinogen in pre-eclampsia[J].Thrombosis Res,2003,111(3):143.
  • 9Friedlander Y,Elkana Y,Sinnreich R,et al.Genetic and environmental sources of fibrinogen variability in Israeli families:the Kibbutzim Family Study[J].Am J Hum Genet,1995,56(5):1194.
  • 10Greer IA.Thrombophilia:implications for pregnancy outcome[J].Thrombosis Res,2003,109(25):73.

同被引文献65

引证文献12

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部